查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1568352

疼痛管理設備市場：行業趨勢和2035年全球預測 - 依設備類型、神經刺激設備類型、應用領域、採購類型、最終用戶和地區

Pain Management Devices Market, Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Device, Type of Neurostimulation Device, Application Area, Mode of Purchase, End User and Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

到2024年，疼痛管理設備市場規模預計將達到 79.4億美元，到2035年的預測期間年複合成長率預計為 4.8%。

疼痛是一種複雜的現象，包括不愉快的感覺體驗，主要與急性或慢性身體損傷有關，並因各種心理、生物和社會因素而加劇。疼痛的盛行率很高，影響全世界很多人。例如，在歐洲，法國和德國約有1.5億人患有慢性疼痛，導致每年超過3000億歐元的經濟負擔。鑑於疼痛在各個地區普遍存在，有效的疼痛管理解決方案對於改善患者的治療效果和提高生活品質非常重要。

疼痛管理通常包括使用疼痛管理設備和治療來減輕肌肉骨骼、脊椎和神經性疼痛患者的痛苦。鴉片類藥物、非類固醇類抗發炎藥、抗憂鬱藥和抗癲癇藥等藥物介入措施是控制和治療急慢性疼痛的第一線藥物。鴉片類藥物是治療中度至重度疼痛最廣泛使用的止痛藥之一，因為起效快，並能立即緩解疼痛。然而，這些藥物具有嚴重的副作用，包括干擾日常活動、減慢心率以及誘發可能導致藥物成癮和死亡的欣快狀態。值得注意的是，2019年，全球約有60萬人因藥物過量死亡，其中近80%與鴉片類藥物過量有關。

鴉片類藥物危機促使行業利益相關者開發了大量以患者為中心的疼痛管理設備，包括神經刺激器、輸液泵和射頻消融設備，以有效管理疼痛。這些設備可作為緩解疼痛的二線治療方法。這些設備具有多種優點，包括藥物交互作用最小或沒有、標靶治療、藥物依賴性低和副作用最小。此外，這些設備可以根據個人的強度和治療時間需求進行定制，提高患者的舒適度。隨著利害關係人繼續研發以患者為中心的設備，全球疼痛管理設備市場預計在預測期內將以健康的年複合成長率成長。

本報告調查了全球疼痛管理設備市場，並提供了市場概述，以及依設備類型、神經刺激設備類型、應用領域、購買形式、最終用戶、地區劃分的趨勢，並提供了進入該市場的公司簡介等。

目錄

第1章 前言

第2章 研究方法

第3章 經濟與其他專案特定考量

第4章 執行摘要

第5章 簡介

  • 章節概述
  • 疼痛及其影響
  • 疼痛的分類
  • 疼痛管理的歷史演變
  • 疼痛管理解決方案的類型
  • 未來前景

第6章 市場情勢：主要疼痛管理設備開發商

  • 章節概述
  • 主要疼痛管理設備開發商：市場狀況

第7章 企業競爭力分析

  • 章節概述
  • 假設和主要參數
  • 調查方法
  • 主要疼痛管理設備開發公司：企業競爭力分析
  • 主要疼痛管理設備開發商：基準分析

第8章 公司簡介

  • 章節概述
  • Abbott
  • Avanos Medical
  • Becton, Dickinson and Company（BD）
  • Medtronic
  • Nalu Medical
  • Nevro
  • ZetrOZ Systems
  • Zynex Medical
  • Key Winning Strategies of Leading Players
  • Other Leading Players
  • Hexainnoheal
  • 其他公司的主要策略

第9章 出版品分析

第10章 波特五力分析

第11章 市場影響分析

  • 章節概述
  • 市場驅動因素
  • 市場限制
  • 市場機會
  • 市場挑戰
  • 結論

第12章 全球疼痛管理設備市場

  • 章節概述
  • 假設與研究方法
  • 到2035年全球疼痛管理設備市場
  • 主要市場細分

第13章 疼痛管理設備市場，依疼痛管理設備類型

第14章 疼痛管理設備市場，依神經刺激設備類型

第15章 疼痛管理設備市場，依應用領域劃分

第16章 疼痛管理設備市場，依購買類型劃分

第17章 疼痛管理設備市場，依最終用戶

第18章 疼痛管理設備市場，依地區

第19章 疼痛管理設備市場，主要產業參與者分析

第20章 結論

第21章 附錄 1：表格資料

第22章 附錄 2：公司與組織名單

Product Code: RAU1026

The Pain Management Devices Market is valued at USD 7.94 billion in 2024 and is anticipated to grow at a CAGR of 4.8 %, during the forecast period, till 2035.

Pain is a complex phenomenon involving unpleasant sensory experience, primarily associated with acute or chronic physical injury exacerbated by various psychological, biological, and social factors. The prevalence of pain is substantial, affecting a significant number of individuals globally. For instance, in Europe, chronic pain affects approximately 150 million individuals, equivalent to the combined population of France and Germany, leading to an annual economic burden of more than EUR 300 billion. Given the widespread prevalence of pain across various geographies, effective pain management solutions are crucial to improve patient outcomes and enhance the quality of life.

Pain management typically involves the use of pain management devices and therapies to alleviate the suffering of individuals with musculoskeletal pain, spinal and neuropathic pain. Pharmacological interventions, such as opioids, nonsteroidal anti-inflammatory drugs, antidepressants, and antiepileptics, serve as a first-line treatment option for managing and treating both acute and chronic pain. Opioids are considered one of the most widely used pain medications for managing moderate to severe pain, owing to their rapid onset of medicinal effect and ability to provide immediate pain relief. However, these drugs are associated with significant side effects, such as inducing a euphoric state that may hamper daily activities, lower heart rate, and potentially lead to drug addiction and death. It is important to note that in 2019, approximately 600,000 deaths were attributed to drug overdose worldwide, with nearly 80% of these deaths related to the overuse of opioids.

The opioid crisis has prompted industry stakeholders to develop a vast array of patient-centric pain management devices, including neurostimulation devices, infusion pumps, and radiofrequency ablation devices, to manage pain effectively. These devices serve as a second-line treatment option for decreasing pain. These devices offer various advantages, such as minimal or no drug interaction, targeted therapy, reduced dependency on medications, and minimal adverse effects. Moreover, these devices can be tailored to individual needs, enabling adjustments in intensity and treatment duration, thereby improving patient comfort. Given the ongoing research and development efforts of stakeholders to develop patient-centric devices, the global pain management devices market is expected to grow at a healthy CAGR during the forecast period.

Key Market Segments

Type of Device

  • Neurostimulation Devices
  • Infusion Pump
  • Ablation Devices
  • Virtual Reality Devices
  • Other Devices

Type of Neurostimulation Device

  • Spinal Cord Stimulators
  • Peripheral Nerve Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Deep Brain Stimulators
  • Other Stimulators

Application Area

  • Neuropathic Pain
  • Musculoskeletal Pain
  • Cancer Pain
  • Trauma and Surgical Pain
  • Facial Pain and Migraine
  • Other Application Areas

Mode of Purchase

  • Prescription
  • Over-the-Counter

End User

  • Hospitals and Clinics
  • Physiotherapy Centers
  • Other End Users

Geographical Regions

  • North America (US, Canada)
  • Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific (Australia, China, India, Indonesia, Japan, South Korea, Rest of Asia-Pacific)
  • Middle East and North Africa (Israel, Saudi Arabia, UAE)
  • Latin America (Brazil, Mexico, Rest of Latin America)

Research Coverage:

  • A brief introduction to pain and its impact, along with classification of pain and the historical development of the pain management domain over the years. It also provides details on various solutions for pain management, including therapeutics and medical devices. The chapter concludes with discussion on the key future perspectives within the pain management industry.
  • An overview of the current market landscape of leading pain management device companies, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, type of device (neurostimulation devices, infusion pump, ablation devices, virtual reality devices and other devices), type of neurostimulation device (spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators), type of ablation device (radiofrequency ablation devices and cryoablation devices), type of analgesic infusion pump (external infusion pump and intrathecal pumps), type of treatment (invasive / minimally invasive and non-invasive), type of pain managed (acute pain and chronic pain), application area (musculoskeletal pain, post-operative pain, neuropathic pain, cancer pain, facial pain and migraine, trauma pain and other application areas).
  • An insightful competitiveness analysis of the leading players engaged in the pain management devices market, based on several relevant parameters, such as company strength (in terms of years of experience and company size), portfolio strength (based on number of devices offered, type of pain management devices offered and type of pain managed) and application area. It also includes benchmarking analysis of the leading players based on various parameters, such as company strength, number of devices offered, type of pain management devices offered, type of pain managed and application area.
  • Elaborate profiles of various prominent players that are currently involved in the pain management devices industry. Each company profile features a brief overview of the company, along with information on the location of headquarters, year of establishment, number of employees, business segments, leadership team, contact details, financial information (if available), product portfolio, recent developments and an informed future outlook.
  • A detailed analysis of over 330 peer-reviewed, scientific articles related to pain management devices, based on several relevant parameters, such as year of publication, type of publication and popular keywords. The chapter also highlights the top journals, top publishers and top copyright holders.
  • A qualitative Porter's five forces analysis, highlighting the five competitive forces prevalent in the pain management devices market, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute products and rivalry among existing competitors.
  • An in-depth analysis of the factors that can impact the growth of the pain management devices industry. It also features the identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
  • A detailed estimate of the current market size, opportunity and the future growth potential for pain management devices, over the next decade. Based on multiple parameters, likely adoption trends and through secondary research, we have provided an informed estimate on the market evolution during the forecast period, till 2035. The report also features the likely distribution of the current and forecasted opportunity. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.
  • A detailed projection of the current size and future opportunity in the pain management devices market across different types of devices, such as neurostimulation devices, infusion pumps, ablation devices, virtual reality devices and other devices.
  • A detailed projection of the current size and future opportunity in the pain management devices industry across different types of neurostimulation devices, such as spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators.
  • A detailed projection of the current size and future opportunity for pain management device companies across different application areas, such as neuropathic pain, musculoskeletal pain, cancer pain, trauma and surgical pain, facial pain and migraine, and other application areas.
  • A detailed projection of the current size and future opportunity in the pain management devices market across different modes of purchase, such as prescription mode and over-the-counter mode.
  • A detailed projection of the current size and future opportunity in the pain management devices industry across different end users, such as hospitals and clinics, physiotherapy centers and other end users.
  • A detailed projection of the current size and future opportunity in the pain management devices market across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.

Key Benefits of Buying this Report

  • The report provides valuable insights to market leaders and newcomers regarding the revenue estimations of the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Pain Management Devices Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Companies Profiled

  • Abbott
  • AppliedVR
  • AtriCure
  • Avanos Medical
  • Becton, Dickinson and Company
  • BioElectronics
  • Hexainnoheal
  • Litemed
  • Medtronic
  • Micrel Medical Devices
  • Nalu Medical
  • Nevro
  • Smileyscope
  • Stryker
  • ZetrOZ Systems
  • Zynex Medical

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Market Share Insights
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Future Estimates
    • 3.2.2. Currency Coverage and Foreign Exchange Rate
      • 3.2.2.1. Major Currencies Affecting the Market
      • 3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
      • 3.2.2.3. Impact of Foreign Exchange Rate Volatility on The Market
      • 3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.3. Trade Policies
      • 3.2.3.1. Impact of Trade Barriers on the Market
      • 3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Pain and Its Impact
  • 5.3. Classification of Pain
    • 5.3.1. Acute Pain
    • 5.3.2. Chronic Pain
  • 5.4. Historical Evolution of Pain Management
  • 5.5. Types of Pain Management Solutions
    • 5.5.1. Pain Management Therapeutics
    • 5.5.2. Pain Management Devices
  • 5.6. Future Perspectives

6. MARKET LANDSCAPE: LEADING PAIN MANAGEMENT DEVICE DEVELOPERS

  • 6.1. Chapter Overview
  • 6.2. Leading Pain Management Device Developers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters
    • 6.2.4. Analysis by Company Size and Location of Headquarters
    • 6.2.5. Analysis by Type of Pain Management Device
      • 6.2.5.1. Analysis by Type of Neurostimulation Device
      • 6.2.5.2. Analysis by Type of Ablation Device
      • 6.2.5.3. Analysis by Type of Analgesic Infusion Pump
    • 6.2.6. Analysis by Type of Treatment
    • 6.2.7. Analysis by Type of Pain Managed
    • 6.2.8. Analysis by Application Area
    • 6.2.9. Analysis by Type of Pain Management Device and Application Area

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology
  • 7.4. Leading Pain Management Device Developers: Company Competitiveness Analysis
  • 7.5. Leading Pain Management Device Developers: Benchmarking Analysis
    • 7.5.1. Benchmarking of Companies
      • 7.5.1.1. Abbott
      • 7.5.1.2. Medtronic
      • 7.5.1.3. Zynex Medical
      • 7.5.1.4. Boston Scientific
      • 7.5.1.5. OMRON Healthcare
    • 7.5.2. Benchmarking of Parameters
      • 7.5.2.1. Leading Pain Management Device Developers: Benchmarking by Competitiveness
      • 7.5.2.2. Leading Pain Management Device Developers: Benchmarking by Portfolio Strength
      • 7.5.2.3. Leading Pain Management Device Developers: Benchmarking by Application Area

8. COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Abbott
    • 8.2.1. Company Overview
    • 8.2.2. Financial Information
    • 8.2.3. Product Portfolio
    • 8.2.4. Recent Developments and Future Outlook
  • 8.3. Avanos Medical
    • 8.3.1. Company Overview
    • 8.3.2. Financial Information
    • 8.3.3. Product Portfolio
    • 8.3.4. Recent Developments and Future Outlook
  • 8.4. Becton, Dickinson and Company (BD)
    • 8.4.1. Company Overview
    • 8.4.2. Financial Information
    • 8.4.3. Product Portfolio
    • 8.4.4. Recent Developments and Future Outlook
  • 8.5. Medtronic
    • 8.5.1. Company Overview
    • 8.5.2. Financial Information
    • 8.5.3. Product Portfolio
    • 8.5.4. Recent Developments and Future Outlook
  • 8.6. Nalu Medical
    • 8.6.1. Company Overview
    • 8.6.2. Financial Information
    • 8.6.3. Product Portfolio
    • 8.6.4. Recent Developments and Future Outlook
  • 8.7. Nevro
    • 8.7.1. Company Overview
    • 8.7.2. Financial Information
    • 8.7.3. Product Portfolio
    • 8.7.4. Recent Developments and Future Outlook
  • 8.8. ZetrOZ Systems
    • 8.8.1. Company Overview
    • 8.8.2. Product Portfolio
    • 8.8.3. Recent Developments and Future Outlook
  • 8.9. Zynex Medical
    • 8.9.1. Company Overview
    • 8.9.2. Financial Information
    • 8.9.3. Product Portfolio
    • 8.9.4. Recent Developments and Future Outlook
  • 8.10. Key Winning Strategies of Leading Players
  • 8.11. Other Leading Players
    • 8.11.1. AppliedVR
    • 8.11.2. AtriCure
    • 8.11.3. BioElectronics

8.11.4.Hexainnoheal

    • 8.11.5. Litemed
    • 8.11.6. Micrel Medical Devices
    • 8.11.7. Smileyscope
    • 8.11.8. Stryker
  • 8.12. Key Winning Strategies of Other Leading Players

9. PUBLICATION ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Pain Management Devices: Publication Analysis
    • 9.3.1. Analysis by Year of Publication
    • 9.3.2. Analysis by Type of Publication
    • 9.3.3. Analysis by Copyright Holders
    • 9.3.4. Word Cloud: Emerging Focus Areas
    • 9.3.5. Most Active Publishers: Analysis by Number of Publications
    • 9.3.6. Key Journals: Analysis by Number of Publications
    • 9.3.7. Key Journals: Analysis by Impact Factor

10. PORTER'S FIVE FORCES ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Methodology and Assumptions
  • 10.3. Key Parameters
    • 10.3.1. Threats of New Entrants
    • 10.3.2. Bargaining Power of End-Users
    • 10.3.3. Bargaining Power of Product Developers
    • 10.3.4. Threats of Substitute Products
    • 10.3.5. Rivalry Among Existing Competitors
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL PAIN MANAGEMENT DEVICES MARKET

  • 12.1. Chapter Overview
  • 12.2. Assumptions and Methodology
  • 12.3. Global Pain Management Devices Market, till 2035
    • 12.3.1. Scenario Analysis
  • 12.4. Key Market Segmentations

13. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF PAIN MANAGEMENT DEVICE

  • 13.1. Chapter Overview
  • 13.2. Assumptions and Methodology
  • 13.3. Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
    • 13.3.1. Pain Management Devices Market for Neurostimulation Devices, till 2035
    • 13.3.2. Pain Management Devices Market for Infusion Pumps, till 2035
    • 13.3.3. Pain Management Devices Market for Ablation Devices, till 2035
    • 13.3.4. Pain Management Devices Market for Virtual Reality Devices, till 2035
    • 13.3.5. Pain Management Devices Market for Other Pain Management Devices, till 2035
  • 13.4. Data Triangulation and Validation

14. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF NEUROSTIMULATION DEVICE

  • 14.1. Chapter Overview
  • 14.2. Assumptions and Methodology
  • 14.3. Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
    • 14.3.1. Pain Management Devices Market for Spinal Cord Stimulators, till 2035
    • 14.3.2. Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035
    • 14.3.3. Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035
    • 14.3.4. Pain Management Devices Market for Deep Brain Stimulators, till 2035
    • 14.3.5. Pain Management Devices Market for Other Stimulators, till 2035
  • 14.4. Data Triangulation and Validation

15. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AREA

  • 15.1. Chapter Overview
  • 15.2. Assumptions and Methodology
  • 15.3. Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
    • 15.3.1. Pain Management Devices Market for Neuropathic Pain, till 2035
    • 15.3.2. Pain Management Devices Market for Musculoskeletal Pain, till 2035
    • 15.3.3. Pain Management Devices Market for Cancer Pain, till 2035
    • 15.3.4. Pain Management Devices Market for Trauma and Surgical Pain, till 2035
    • 15.3.5. Pain Management Devices Market for Facial Pain and Migraine, till 2035
    • 15.3.6. Pain Management Devices Market for Other Application Areas, till 2035
  • 15.4. Data Triangulation and Validation

16. PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

  • 16.1. Chapter Overview
  • 16.2. Assumptions and Methodology
  • 16.3. Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
    • 16.3.1. Pain Management Devices Market for Prescription, till 2035
    • 16.3.2. Pain Management Devices Market for Over-the-Counter, till 2035
  • 16.4. Data Triangulation and Validation

17. PAIN MANAGEMENT DEVICES MARKET, BY END USERS

  • 17.1. Chapter Overview
  • 17.2. Assumptions and Methodology
  • 17.3. Pain Management Devices Market: Distribution by End Users, 2024 and 2035
    • 17.3.1. Pain Management Devices Market for Hospitals and Clinics, till 2035
    • 17.3.2. Pain Management Devices Market for Physiotherapy Centers, till 2035
    • 17.3.3. Pain Management Devices Market for Other End Users, till 2035
  • 17.4. Data Triangulation and Validation

18. PAIN MANAGEMENT DEVICES MARKET, BY GEOGRAPHICAL REGIONS

  • 18.1. Chapter Overview
  • 18.2. Assumptions and Methodology
  • 18.3. Pain Management Devices Market: Distribution by Geographical Regions, 2024 and 2035
    • 18.3.1. Pain Management Devices Market in North America, till 2035
      • 18.3.1.1. Pain Management Devices Market in the US, till 2035
      • 18.3.1.2. Pain Management Devices Market in Canada, till 2035
    • 18.3.2. Pain Management Devices Market in Europe, till 2035
      • 18.3.2.1. Pain Management Devices Market in Germany, till 2035
      • 18.3.2.2. Pain Management Devices Market in France, till 2035
      • 18.3.2.3. Pain Management Devices Market in the UK, till 2035
      • 18.3.2.4. Pain Management Devices Market in Spain, till 2035
      • 18.3.2.5. Pain Management Devices Market in Italy, till 2035
      • 18.3.2.6. Pain Management Devices Market in Rest of Europe, till 2035
    • 18.3.3. Pain Management Devices Market in Asia-Pacific, till 2035
      • 18.3.3.1. Pain Management Devices Market in China, till 2035
      • 18.3.3.2. Pain Management Devices Market in Japan, till 2035
      • 18.3.3.3. Pain Management Devices Market in Australia, till 2035
      • 18.3.3.4. Pain Management Devices Market in India, till 2035
      • 18.3.3.5. Pain Management Devices Market in South Korea, till 2035
      • 18.3.3.6. Pain Management Devices Market in Rest of Asia-Pacific, till 2035
    • 18.3.4. Pain Management Devices Market in Middle East and North Africa, till 2035
      • 18.3.4.1. Pain Management Devices Market in Israel, till 2035
      • 18.3.4.2. Pain Management Devices Market in Saudi Arabia, till 2035
      • 18.3.4.3. Pain Management Devices Market in UAE, till 2035
    • 18.3.5. Pain Management Devices Market in Latin America, till 2035
      • 18.3.5.1. Pain Management Devices Market in Brazil, till 2035
      • 18.3.5.2. Pain Management Devices Market in Mexico, till 2035
      • 18.3.5.3. Pain Management Devices Market in Rest of Latin America, till 2035
  • 18.4. Geographical Regions: Market Movement Analysis
  • 18.5. Geographical Regions: Penetration-Growth (P-G) Matrix
  • 18.6. Data Triangulation and Validation

19. PAIN MANAGEMENT DEVICES MARKET, BY LEADING INDUSTRY PLAYERS

  • 19.1. Chapter Overview
  • 19.2. Leading Industry Players

20. CONCLUSION

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION

List of Tables

  • Table 6.1 Leading Pain Management Device Developers: Information on Year of Establishment, Company Size, Location of Headquarters and Devices
  • Table 6.2 Leading Pain Management Device Developers: Information on Type of Pain Management Device
  • Table 6.3 Leading Pain Management Device Developers: Information on Type of Treatment and Type of Pain Managed
  • Table 6.4 Leading Pain Management Device Developers: Information on Application Area
  • Table 8.1 Leading Pain Management Device Developers: List of Companies Profiled
  • Table 8.2 Abbott: Company Overview
  • Table 8.3 Abbott: Pain Management Devices Portfolio
  • Table 8.4 Abbott: Recent Developments and Future Outlook
  • Table 8.5 Avanos Medical: Company Overview
  • Table 8.6 Avanos Medical: Pain Management Devices Portfolio
  • Table 8.7 Avanos Medical: Recent Developments and Future Outlook
  • Table 8.8 Becton, Dickinson and Company: Company Overview
  • Table 8.9 Becton, Dickinson and Company (BD): Pain Management Devices Portfolio
  • Table 8.10 Becton, Dickinson and Company (BD): Recent Developments and Future Outlook
  • Table 8.11 Medtronic: Company Overview
  • Table 8.12 Medtronic: Pain Management Devices Portfolio
  • Table 8.13 Medtronic: Recent Developments and Future Outlook
  • Table 8.14 Nalu Medical: Company Overview
  • Table 8.15 Nalu Medical: Pain Management Device Portfolio
  • Table 8.16 Nalu Medical: Recent Developments and Future Outlook
  • Table 8.17 Nevro: Company Overview
  • Table 8.18 Nevro: Pain Management Devices Portfolio
  • Table 8.19 Nevro: Recent Developments and Future Outlook
  • Table 8.20 ZetrOZ Systems: Company Overview
  • Table 8.21 ZetrOZ Systems: Pain Management Devices Portfolio
  • Table 8.22 ZetrOZ Systems: Recent Developments and Future Outlook
  • Table 8.23 Zynex Medical: Company Overview
  • Table 8.24 Zynex Medical: Pain Management Devices Portfolio
  • Table 8.25 Zynex Medical: Recent Developments and Future Outlook
  • Table 8.26 AppliedVR: Company Overview
  • Table 8.27 AppliedVR: Pain Management Device Portfolio
  • Table 8.28 AtriCure: Company Overview
  • Table 8.29 AtriCure: Pain Management Device Portfolio
  • Table 8.30 BioElectronics: Company Overview
  • Table 8.31 BioElectronics: Pain Management Devices Portfolio
  • Table 8.32 Hexainnoheal: Company Overview
  • Table 8.33 Hexainnoheal: Pain Management Device Portfolio
  • Table 8.34 Litemed: Company Overview
  • Table 8.35 Litemed: Pain Management Device Portfolio
  • Table 8.36 Micrel Medical Devices: Company Overview
  • Table 8.37 Micrel Medical Devices: Pain Management Devices Portfolio
  • Table 8.38 Smileyscope: Company Overview
  • Table 8.39 Smileyscope: Pain Management Device Portfolio
  • Table 8.40 Stryker: Company Overview
  • Table 8.41 Stryker: Pain Management Device Portfolio
  • Table 21.1 Leading Pain Management Device Developers: Distribution by Year of Establishment
  • Table 21.2 Leading Pain Management Device Developers: Distribution by Company Size
  • Table 21.3 Leading Pain Management Device Developers: Distribution by Location of Headquarters
  • Table 21.4 Leading Pain Management Device Developers: Distribution by Company Size and Location of Headquarters
  • Table 21.5 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device
  • Table 21.6 Leading Pain Management Device Developers: Distribution by Type of Neurostimulation Device
  • Table 21.7 Leading Pain Management Device Developers: Distribution by Type of Ablation Device
  • Table 21.8 Leading Pain Management Device Developers: Distribution by Type of Analgesic Infusion Pump
  • Table 21.9 Leading Pain Management Device Developers: Distribution by Type of Treatment
  • Table 21.10 Leading Pain Management Device Developers: Distribution by Type of Pain Managed
  • Table 21.11 Leading Pain Management Device Developers: Distribution by Application Area
  • Table 21.12 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device and Application Area
  • Table 21.13 Publication Analysis: Cumulative Year-Wise Trend, since 2019
  • Table 21.14 Publication Analysis: Distribution by Type of Publication
  • Table 21.15 Publication Analysis: Distribution by Copyright Holders
  • Table 21.16 Most Active Publishers: Distribution by Number of Publications
  • Table 21.17 Key Journals: Distribution by Number of Publications
  • Table 21.18 Key Journals: Distribution by Impact Factor
  • Table 21.19 Global Pain Management Devices Market, till 2035: Base Scenario (USD Billion)
  • Table 21.20 Global Pain Management Devices Market, till 2035: Conservative Scenario (USD Billion)
  • Table 21.21 Global Pain Management Devices Market, till 2035: Optimistic Scenario (USD Billion)
  • Table 21.22 Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
  • Table 21.23 Pain Management Devices Market for Neurostimulation Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.24 Pain Management Devices Market for Infusion Pumps, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.25 Pain Management Devices Market for Ablation Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.26 Pain Management Devices Market for Virtual Reality Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.27 Pain Management Devices Market for Other Pain Management Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.28 Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
  • Table 21.29 Pain Management Devices Market for Spinal Cord Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.30 Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.31 Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.32 Pain Management Devices Market for Deep Brain Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.33 Pain Management Devices Market for Other Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.34 Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
  • Table 21.35 Pain Management Devices Market for Neuropathic Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.36 Pain Management Devices Market for Musculoskeletal Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.37 Pain Management Devices Market for Cancer Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.38 Pain Management Devices Market for Trauma and Surgical Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.39 Pain Management Devices Market for Facial Pain and Migraine, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.40 Pain Management Devices Market for Other Application Areas, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.41 Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
  • Table 21.42 Pain Management Devices Market for Prescription, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.43 Pain Management Devices Market for Over-the-Counter, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.44 Pain Management Devices Market: Distribution by End Users, 2024 and 2035
  • Table 21.45 Pain Management Devices Market for Hospitals and Clinics, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.46 Pain Management Devices Market for Physiotherapy Centers, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.47 Pain Management Devices Market for Other End Users, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.48 Pain Management Devices Market: Distribution by Key Geographical Regions, 2024 and 2035
  • Table 21.49 Pain Management Devices Market in North America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.50 Pain Management Devices Market in the US, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.51 Pain Management Devices Market in Canada, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.52 Pain Management Devices Market in Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.53 Pain Management Devices Market in Germany, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.54 Pain Management Devices Market in France, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.55 Pain Management Devices Market in the UK, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.56 Pain Management Devices Market in Spain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.57 Pain Management Devices Market in Italy, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.58 Pain Management Devices Market in Rest of Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.59 Pain Management Devices Market in Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.60 Pain Management Devices Market in China, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.61 Pain Management Devices Market in Japan, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.62 Pain Management Devices Market in Australia, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.63 Pain Management Devices Market in India, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.64 Pain Management Devices Market in South Korea, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.65 Pain Management Devices Market in Rest of Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.66 Pain Management Devices Market in Middle East and North Africa, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.67 Pain Management Devices Market in Israel, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.68 Pain Management Devices Market in Saudi Arabia, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.69 Pain Management Devices Market in UAE, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.70 Pain Management Devices Market in Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.71 Pain Management Devices Market in Brazil, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.72 Pain Management Devices Market in Mexico, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.73 Pain Management Devices Market in Rest of Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

  • Figure 2.1 Research Methodology: Project Methodology
  • Figure 2.2 Research Methodology: Secondary Research: Data Sources
  • Figure 3.1 Lessons Learnt from Past Recessions
  • Figure 4.1 Executive Summary: Pain Management Device Developers: Market Landscape of Leading Players
  • Figure 4.2 Executive Summary: Publication Analysis
  • Figure 4.3 Executive Summary: Pain Management Devices: Market Forecast and Opportunity Analysis
  • Figure 5.1 Classification of Pain
  • Figure 5.2 Types of Pain Management Therapeutics
  • Figure 6.1 Leading Pain Management Device Developers: Distribution by Year of Establishment
  • Figure 6.2 Leading Pain Management Device Developers: Distribution by Company Size
  • Figure 6.3 Leading Pain Management Device Developers: Distribution by Location of Headquarters
  • Figure 6.4 Leading Pain Management Device Developers: Distribution by Company Size and Location of Headquarters
  • Figure 6.5 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device
  • Figure 6.6 Leading Pain Management Device Developers: Distribution by Type of Neurostimulation Device
  • Figure 6.7 Leading Pain Management Device Developers: Distribution by Type of Ablation Device
  • Figure 6.8 Leading Pain Management Device Developers: Distribution by Type of Analgesic Infusion Pump
  • Figure 6.9 Leading Pain Management Device Developers: Distribution by Type of Treatment
  • Figure 6.10 Leading Pain Management Device Developers: Distribution by Type of Pain Managed
  • Figure 6.11 Leading Pain Management Device Developers: Distribution by Application Area
  • Figure 6.12 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device and Application Area
  • Figure 7.1 Leading Pain Management Device Developers: 3-D Bubble Chart
  • Figure 7.2 Abbott
  • Figure 7.3 Medtronic
  • Figure 7.4 Zynex Medical
  • Figure 7.5 Boston Scientific
  • Figure 7.6 OMRON Healthcare
  • Figure 7.7 Leading Pain Management Device Developers: Benchmarking by Competitiveness
  • Figure 7.8 Leading Pain Management Device Developers: Benchmarking by Portfolio Strength
  • Figure 7.9 Leading Pain Management Device Developers: Benchmarking by Application Area
  • Figure 8.1 Abbott: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
  • Figure 8.2 Avanos Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
  • Figure 8.3 Becton, Dickinson and Company (BD): Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
  • Figure 8.4 Medtronic: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
  • Figure 8.5 Nalu Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
  • Figure 8.6 Nevro: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
  • Figure 8.7 Zynex Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
  • Figure 8.8 Key Winning Strategies of Leading Players
  • Figure 8.9 Key Winning Strategies of Other Leading Players
  • Figure 9.1 Publication Analysis: Cumulative Year-Wise Trend, since 2019
  • Figure 9.2 Publication Analysis: Distribution by Type of Publication
  • Figure 9.3 Publication Analysis: Distribution by Copyright Holders
  • Figure 9.4 Word Cloud Analysis: Emerging Focus Areas
  • Figure 9.5 Most Active Publishers: Distribution by Number of Publications
  • Figure 9.6 Key Journals: Distribution by Number of Publications
  • Figure 9.7 Key Journals: Distribution by Impact factor
  • Figure 10.1 Porter's Five Forces: Harvey Ball Analysis
  • Figure 10.2 Threats of New Entrants
  • Figure 10.3 Bargaining Power of Buyers
  • Figure 10.4 Bargaining Power of Suppliers
  • Figure 10.5 Threats of Substitute Products
  • Figure 10.6 Rivalry among Existing Competitors
  • Figure 10.7 Porter's Five Forces: Concluding Remarks
  • Figure 11.1 Market Drivers
  • Figure 11.2 Market Restraints
  • Figure 11.3 Market Opportunities
  • Figure 11.4 Market Challenges
  • Figure 12.1 Global Pain Management Devices Market, till 2035: Base Scenario (USD Billion)
  • Figure 12.2 Global Pain Management Devices Market, till 2035: Conservative Scenario (USD Billion)
  • Figure 12.3 Global Pain Management Devices Market, till 2035: Optimistic Scenario (USD Billion)
  • Figure 13.1 Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
  • Figure 13.2 Pain Management Devices Market for Neurostimulation Devices, till 2035
  • Figure 13.3 Pain Management Devices Market for Infusion Pumps, till 2035
  • Figure 13.4 Pain Management Devices Market for Ablation Devices, till 2035
  • Figure 13.5 Pain Management Devices Market for Virtual Reality Devices, till 2035
  • Figure 13.6 Pain Management Devices Market for Other Pain Management Devices, till 2035
  • Figure 14.1 Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
  • Figure 14.2 Pain Management Devices Market for Spinal Cord Stimulators, till 2035
  • Figure 14.3 Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035
  • Figure 14.4 Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035
  • Figure 14.5 Pain Management Devices Market for Deep Brain Stimulators, till 2035
  • Figure 14.6 Pain Management Devices Market for Other Stimulators, till 2035
  • Figure 15.1 Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
  • Figure 15.2 Pain Management Devices Market for Neuropathic Pain, till 2035
  • Figure 15.3 Pain Management Devices Market for Musculoskeletal Pain, till 2035
  • Figure 15.4 Pain Management Devices Market for Cancer Pain, till 2035
  • Figure 15.5 Pain Management Devices Market for Trauma and Surgical Pain, till 2035
  • Figure 15.6 Pain Management Devices Market for Facial Pain and Migraine, till 2035
  • Figure 15.7 Pain Management Devices Market for Other Application Areas, till 2035
  • Figure 16.1 Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
  • Figure 16.2 Pain Management Devices Market for Prescription, till 2035
  • Figure 16.3 Pain Management Devices Market for Over-the-Counter, till 2035
  • Figure 17.1 Pain Management Devices Market: Distribution by End Users, 2024 and 2035
  • Figure 17.2 Pain Management Devices Market for Hospitals and Clinics, till 2035
  • Figure 17.3 Pain Management Devices Market for Physiotherapy Centers, till 2035
  • Figure 17.4 Pain Management Devices Market for Other End Users, till 2035
  • Figure 18.1 Pain Management Devices Market: Distribution by Geographical Regions, 2024 and 2035
  • Figure 18.2 Pain Management Devices Market in North America, till 2035
  • Figure 18.3 Pain Management Devices Market in the US, till 2035
  • Figure 18.4 Pain Management Devices Market in Canada, till 2035
  • Figure 18.5 Pain Management Devices Market in Europe, till 2035
  • Figure 18.6 Pain Management Devices Market in Germany, till 2035
  • Figure 18.7 Pain Management Devices Market in France, till 2035
  • Figure 18.8 Pain Management Devices Market in the UK, till 2035
  • Figure 18.9 Pain Management Devices Market in Spain, till 2035
  • Figure 18.10 Pain Management Devices Market in Italy, till 2035
  • Figure 18.11 Pain Management Devices Market in Rest of Europe, till 2035
  • Figure 18.12 Pain Management Devices Market in Asia-Pacific, till 2035
  • Figure 18.13 Pain Management Devices Market in China, till 2035
  • Figure 18.14 Pain Management Devices Market in Japan, till 2035
  • Figure 18.15 Pain Management Devices Market in Australia, till 2035
  • Figure 18.16 Pain Management Devices Market in India, till 2035
  • Figure 18.17 Pain Management Devices Market in South Korea, till 2035
  • Figure 18.18 Pain Management Devices Market in Rest of Asia-Pacific, till 2035
  • Figure 18.19 Pain Management Devices Market in Middle East and North Africa, till 2035
  • Figure 18.20 Pain Management Devices Market in Israel, till 2035
  • Figure 18.21 Pain Management Devices Market in Saudi Arabia, till 2035
  • Figure 18.22 Pain Management Devices Market in UAE, till 2035
  • Figure 18.23 Pain Management Devices Market in Latin America, till 2035
  • Figure 18.24 Pain Management Devices Market in Brazil, till 2035
  • Figure 18.25 Pain Management Devices Market in Mexico, till 2035
  • Figure 18.26 Pain Management Devices Market in Rest of Latin America, till 2035
  • Figure 18.27 Geographical Regions: Market Movement Analysis
  • Figure 18.28 Geographical Regions: Penetration-Growth (P-G) Matrix
  • Figure 20.1 Conclusion: Pain Management Device Developers Market Landscape
  • Figure 20.2 Conclusion: Publication Analysis
  • Figure 20.3 Conclusion: Market Forecast and Opportunity Analysis (I/II)
  • Figure 20.4 Conclusion: Market Forecast and Opportunity Analysis (II/II)